{"nct_id":"NCT01279473","title":"Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)","status":"COMPLETED","status_verified_date":"2011-08","start_date":"2005-08","start_date_type":null,"primary_completion_date":"2009-12","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE1","PHASE2"],"tickers":["NVS"]}